Showing results (1-10 of 274) with videos related to
Sort By:
Pageof 28
British Journal of Haematology|April 26, 2017
An update for Richter syndrome - new directions and developmentsToby A Eyre, Anna SchuhBMC Cancer|March 17, 2015
Single arm NCRI phase II study of CHOP in combination with Ofatumumab in induction and maintenance for patients with newly diagnosed Richter's syndromeToby A Eyre, Ruth Clifford, Corran Roberts, et al.British Journal of Haematology|June 14, 2026
Where next for BTKi-BCL2i combinations in mantle cell lymphoma?Toby A EyreHematology. American Society of Hematology. Education Program|December 9, 2023
Richter transformation-is there light at the end of this tunnel?Toby A EyreOncotarget|March 23, 2019
Correction: Predictive biomarkers for disease sensitivity in lymphoma - the holy grail for HDAC inhibitors?Toby A EyreBMC Cancer|May 22, 2019
The STELLAR trial protocol: a prospective multicentre trial for Richter's syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed diseaseNiamh Appleby, Toby A Eyre, Maite Cabes, et al.British Journal of Haematology|April 1, 2015
Immune checkpoint inhibition in lymphoid diseaseToby A Eyre, Graham P CollinsCancers|May 13, 2023
The Evolution of Therapies Targeting Bruton Tyrosine Kinase for the Treatment of Chronic Lymphocytic Leukaemia: Future PerspectivesToby A Eyre, John C RichesEuropean Journal of Haematology|July 24, 2022
Venetoclax induces deep and durable minimal residual disease-negative remission in high-risk TP53 disrupted B prolymphocytic leukaemiaLucia Y Chen, Toby A EyreHematological Oncology|October 29, 2021
Treatment strategies for a rapidly evolving landscape in chronic lymphocytic leukemia managementToby A Eyre, Satoshi Hori, Talha MunirPageof 28